1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)-

1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)- Basic information
Product Name:1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)-
Synonyms:1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)-
CAS:302-96-5
MF:C21H32N2O
MW:328.49158
EINECS:
Product Categories:
Mol File:302-96-5.mol
1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)- Structure
1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)- Chemical Properties
Boiling point 466.22°C (rough estimate)
density 1.0279 (rough estimate)
refractive index 1.6500 (estimate)
Safety Information
ToxicityTDLo orl-wmn: 24 mg/kg/17W-I:SYS BMJOAE294,612,87
MSDS Information
1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)- Usage And Synthesis
DefinitionChEBI: Stanozolol is an organic heteropentacyclic compound resulting from the formal condensation of the 3-keto-aldehyde moiety of oxymetholone with hydrazine. Like oxymetholone, it is a synthetic anabolic steroid. It has both anabolic and androgenic properties, and has been used to treat hereditary angioedema and various vascular disorders. It has also been widely abused by professional athletes. It has a role as an androgen and an anabolic agent. It is a 17beta-hydroxy steroid, a tertiary alcohol, an anabolic androgenic steroid and an organic heteropentacyclic compound. It is functionally related to an oxymetholone.
Safety ProfileHuman systemic effects byingestion: jaundice. An experimental teratogen. Otherexperimental reproductive effects. When heated todecomposition it emits toxic fumes of NOx.
1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)- Preparation Products And Raw materials
Tag:1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)-(302-96-5) Related Product Information